Simvastatin label revised, again
Links shared publicly online about this topic.
- 0total visits
Simvastatin label revised, again
Merck’s simvastatin (Zocor) is in the news yet again. This time the FDA has revised the cholesterol-lowering drug’s dosing limitations from 10 mg to 20 mg when it is administered alongside the antiarrhythmic drug amiodarone.
View full resource at cardiovascularbusiness.com
Tags: Cholesterol Medication, Drug, FDA, Zocor, Merck & Co., News
Most Recently Shared on December 15, 2011 at 10:32 pm By:
Simvastatin label revised, again - Merck’s simvastatin (Zocor) is in the news yet again. This time the FDA has revi... http://t.co/0lBr9XSh
Therapeutics Daily
therapeuticsdaily.com — “Therapeutics Daily” View full resource at therapeuticsdaily.com
Most Recently Shared on June 10, 2011 at 7:30 pm By:
PharmaLive Pharma and Health News
Therapeutics Daily - FDA Revises Simvastatin Label - http://tinyurl.com/3no7p66
Advertisement
